Delivery Order SPE2DB22D9316-SPE2DB25FYP95
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $61,258.56 firm fixed-price contract is for the procurement of ADCETRIS 50 MG vials, with a period of performance through May 22, 2024. DMS Pharmaceutical Group holds a single-award, indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 50 mg vials of ADCETRIS. The contract has a potential value of $74,020.36 and a completion date of February 20, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of branded and generic pharmaceutical products and medical supplies to federal agencies,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $45,943.92 order is for the pharmaceutical product ADCETRIS 50 MG VIALS, with a completion date of February 13, 2024. This delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to provide a variety of pharmaceutical and medical supplies to military treatment facilities worldwide, with a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 29, 2025, for the supply of Adcetris 50 mg vials, an oncology medication. The contract carries a ceiling value of approximately $64,054 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 19, 2025. This award was funded by the Defense Logistics Agency's Medical Supply Chain division and includes...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $44,728.26, covers the delivery of ADCETRIS 50 MG VIALS, a specialized pharmaceutical product, with a period of performance through November 30, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- This is a $61,258.56 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The order is for the supply of ADCETRIS 50 MG vials, a chemotherapy drug, with a performance period extending through April 2024. This award is under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with DLA, contract number SPE2DB-13-D-4600, which has a maximum value of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $22,971.96 firm fixed-price contract is for the delivery of ADCETRIS 50 MG vials, a chemotherapy drug. The contract has an ultimate completion date of April 22, 2024. DMS Pharmaceutical Group Inc. holds a separate indefinite delivery contract with the DLA under the SPE2DB program, valued at up to...
- This is a firm fixed-price delivery order for the pharmaceutical product ADCETRIS 50 MG VIALS, awarded by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $81,197.80 and an ultimate completion date of April 10, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-four thousand five hundred forty-seven dollars and ten cents ($74,547.10) by the Defense Logistics Agency. The delivery order is for ADCETRIS 50 MG vials to fulfill requirements under the prime vendor's indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,479.16 contract is for the delivery of ADCETRIS 50 MG VIALS, a specialized oncology medication, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB25FYP95Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $48,718.74 to DMS Pharmaceutical Group Inc. for the supply of Adcetris 50 mg vials, with an ultimate completion date of September 22, 2025. This delivery order was issued without a set-aside designation and represents a continuation of DMS Pharmaceutical Group's ongoing pharmaceutical supply relationship with DLA. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, is the prime contractor on this award and will serve as the sole vendor for this delivery order. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support medical supply needs of military healthcare facilities worldwide. Adcetris, an oncology treatment, aligns with the contractor's established portfolio of specialty medications and represents part of DMS Pharmaceutical Group's critical role in supplying branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.7k | 8/29/25 |